Acute exacerbation of interstitial lung disease after procedures

William H. Amundson, Emilian Racila, Tadashi Allen, H. Erhan Dincer, Rade Tomic, Maneesh Bhargava, David M. Perlman, Hyun Joo Kim*

*Corresponding author for this work

Research output: Contribution to journalReview article

Abstract

Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

Original languageEnglish (US)
Pages (from-to)30-37
Number of pages8
JournalRespiratory Medicine
Volume150
DOIs
StatePublished - Apr 1 2019

Fingerprint

Interstitial Lung Diseases
Idiopathic Pulmonary Fibrosis
Decision Making
Fibrosis
Inflammation
Lung

Keywords

  • AE-ILD
  • Acute exacerbation
  • Acute exacerbation of interstitial lung disease
  • Interstitial lung disease
  • Lung biopsy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Amundson, W. H., Racila, E., Allen, T., Dincer, H. E., Tomic, R., Bhargava, M., ... Kim, H. J. (2019). Acute exacerbation of interstitial lung disease after procedures. Respiratory Medicine, 150, 30-37. https://doi.org/10.1016/j.rmed.2019.02.012
Amundson, William H. ; Racila, Emilian ; Allen, Tadashi ; Dincer, H. Erhan ; Tomic, Rade ; Bhargava, Maneesh ; Perlman, David M. ; Kim, Hyun Joo. / Acute exacerbation of interstitial lung disease after procedures. In: Respiratory Medicine. 2019 ; Vol. 150. pp. 30-37.
@article{877c71cfe6804e2cae2731cdd3342c14,
title = "Acute exacerbation of interstitial lung disease after procedures",
abstract = "Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.",
keywords = "AE-ILD, Acute exacerbation, Acute exacerbation of interstitial lung disease, Interstitial lung disease, Lung biopsy",
author = "Amundson, {William H.} and Emilian Racila and Tadashi Allen and Dincer, {H. Erhan} and Rade Tomic and Maneesh Bhargava and Perlman, {David M.} and Kim, {Hyun Joo}",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.rmed.2019.02.012",
language = "English (US)",
volume = "150",
pages = "30--37",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "W.B. Saunders Ltd",

}

Amundson, WH, Racila, E, Allen, T, Dincer, HE, Tomic, R, Bhargava, M, Perlman, DM & Kim, HJ 2019, 'Acute exacerbation of interstitial lung disease after procedures', Respiratory Medicine, vol. 150, pp. 30-37. https://doi.org/10.1016/j.rmed.2019.02.012

Acute exacerbation of interstitial lung disease after procedures. / Amundson, William H.; Racila, Emilian; Allen, Tadashi; Dincer, H. Erhan; Tomic, Rade; Bhargava, Maneesh; Perlman, David M.; Kim, Hyun Joo.

In: Respiratory Medicine, Vol. 150, 01.04.2019, p. 30-37.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Acute exacerbation of interstitial lung disease after procedures

AU - Amundson, William H.

AU - Racila, Emilian

AU - Allen, Tadashi

AU - Dincer, H. Erhan

AU - Tomic, Rade

AU - Bhargava, Maneesh

AU - Perlman, David M.

AU - Kim, Hyun Joo

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

AB - Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

KW - AE-ILD

KW - Acute exacerbation

KW - Acute exacerbation of interstitial lung disease

KW - Interstitial lung disease

KW - Lung biopsy

UR - http://www.scopus.com/inward/record.url?scp=85061673819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061673819&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2019.02.012

DO - 10.1016/j.rmed.2019.02.012

M3 - Review article

VL - 150

SP - 30

EP - 37

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

ER -